Position in PTGX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$17,317,979
+$726,649 QoQ
Shares Held
141,279
-10.2% QoQ
Ownership
0.218%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#58
of 341 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 51%
Shared 0%
None 49%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. PTGX ranks #19 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in PTGX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,317,979 | 141,279 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $16,591,330 | 157,413 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $13,533,333 | 154,950 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $10,893,191 | 163,980 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $9,563,257 | 173,028 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $7,837,463 | 162,065 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $6,251,810 | 161,964 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $7,388,010 | 164,178 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,944,383 | 84,975 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $2,458,731 | 84,989 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,909,885 | 83,292 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,381,254 | 82,809 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $2,151,901 | 77,911 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,718,307 | 74,709 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $776,279 | 71,153 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $594,458 | 70,517 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $526,537 | 66,566 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,099,367 | 46,426 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,503,739 | 43,969 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $756,555 | 42,695 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,831,642 | 40,812 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $860,268 | 33,215 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $680,097 | 33,735 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $575,669 | 29,446 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $524,078 | 29,676 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $117,697 | 16,671 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||